Alzheimer disease seen through the lens of sex and gender

Laura Castro-Aldrete, Melanie Einsiedler, Julie Novakova Martinkova, Herman Depypere, Ting Fang Alvin Ang, Michelle M. Mielke, Shireen Sindi, Harris A. Eyre, Rhoda Au, Anne Marie Schumacher Dimech, Anna Dé, Cassandra Szoeke, Maria Carmela Tartaglia, Antonella Santuccione Chadha

Research output: Contribution to journalReview articlepeer-review

Abstract

Alzheimer disease (AD) is a life-limiting neurodegenerative disorder that disproportionately affects women. Indeed, sex and gender are emerging as crucial modifiers of diagnostic and therapeutic pathways in AD. This Review provides an overview of the interactions of sex and gender with important developments in AD and offers insights into priorities for future research to facilitate the development and implementation of personalized approaches in the shifting paradigm of AD care. In particular, this Review focuses on the influence of sex and gender on important advances in the treatment and diagnosis of AD, including disease-modifying therapies, fluid-based biomarkers, cognitive assessment tools and multidomain lifestyle interventional studies.

Original languageEnglish (US)
Article numbere0231848
Pages (from-to)235-249
Number of pages15
JournalNature Reviews Neurology
Volume21
Issue number5
DOIs
StatePublished - May 2025

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Alzheimer disease seen through the lens of sex and gender'. Together they form a unique fingerprint.

Cite this